Correlation Between Takeda Pharmaceutical and Dr Reddys

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical and Dr Reddys Laboratories, you can compare the effects of market volatilities on Takeda Pharmaceutical and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Dr Reddys.

Diversification Opportunities for Takeda Pharmaceutical and Dr Reddys

0.14

Correlation Coefficient

Takeda Pharmaceutical  Dr Reddys

Average diversification

The 3 months correlation between Takeda and RDDA is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Dr Reddys go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Dr Reddys

Assuming the 90 days horizon Takeda Pharmaceutical is expected to under-perform the Dr Reddys. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical is 1.32 times less risky than Dr Reddys. The stock trades about -0.02 of its potential returns per unit of risk. The Dr Reddys Laboratories is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  1,350  in Dr Reddys Laboratories on October 1, 2024 and sell it today you would earn a total of  120.00  from holding Dr Reddys Laboratories or generate 8.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Takeda Pharmaceutical  vs.  Dr Reddys Laboratories

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Dr Reddys Laboratories

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Takeda Pharmaceutical and Dr Reddys

The main advantage of trading using opposite Takeda Pharmaceutical and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.

The idea behind Takeda Pharmaceutical and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.